ARTICLE | Clinical News
Fiasp regulatory update
January 13, 2017 8:51 PM UTC
The European Commission approved Fiasp insulin aspart from Novo Nordisk to treat diabetes in adults. Novo Nordisk plans to launch Fiasp, a faster-acting insulin aspart formulation, in Europe this half...
BCIQ Company Profiles
BCIQ Target Profiles